Skip to main content

Table 3 Odds ratio and 95% confidence interval for cardiometabolic risk factors: the CASPIAN-V study

From: Are non-high–density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study

Variable Model High TC High LDL MetS Low HDL Overweight Abdominal obesity Obesity High FBS High TG High BP
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Non-HDL-C (mg/dl) Model I 1.19
(1.17,1.22)* 		1.19
(1.17,1.20)* 		1.01
(1.00,1.01)* 		0.99
(0.99,0.99)* 		1.00
(0.99,1.00) 		1.00
(0.99,1.00) 		1.00
(0.99,1.00) 		1.00
(1.00,1.01) 		1.03
(1.03,1.03)* 		0.99
(0.99,1.00)
Model II 1.19
(1.16,1.22)* 		1.19
(1.17,1.21)* 		1.01
(1.00, 1.01)* 		0.99
(0.99,0.99)* 		1.00
(0.99,1.00) 		1.00
(0.99,1.00) 		1.00
(0.99,1.00) 		1.00
(.99,1.01) 		1.03
(1.02,1.03)* 		0.99
(0.99,1.00)
Model III 1.19
(1.16,1.22)* 		1.19
(1.17,1.21)* 		1.01
(1.00, 1.01)* 		0.99
(0.99,0.99)* 		– – – 1.00
(.99,1.01) 		1.03
(1.02,1.03)* 		0.99
(0.99,1.01)
Diff-C (mg/dl) Model I 1.07
(1.06,1.08)* 		1.02
(1.01,1.02)* 		1.07 (1.06,1.09)* 1.04
(1.03,1.05)* 		1.01
(1.00,1.02)* 		1.00
(0.99,1.01) 		1.00
(0.99,1.01) 		1.04
(1.02,1.05)* 		1.02
(1.01,1.02)* 		1.00
(0.98,1.01)
Model II 1.07
(1.06,1.09)* 		1.02
(1.01,1.03)* 		1.08
(1.07,1.01)* 		1.04
(1.04,1.05)* 		1.01
(1.00,1.02)* 		1.00
(0.99,1.01) 		1.00
(0.99,1.01) 		1.03
(1.02,1.05)* 		1.03
(1.02,1.04)* 		1.00
(0.99,1.01)
Model III 1.07
(1.06,1.09)* 		1.02
(1.01,1.03)* 		1.08
(1.07, 1.10)* 		1.04
(1.04,1.05)* 		– – – 1.03
(1.02,1.05)* 		1.02
(1.01,1.03)* 		1.00
(0.98,1.01)
Atherogenic index Model I 1.36
(1.26,1.46)* 		1.02
(0.96,1.08) 		1.8
(1.7, 2.00)* 		2.43
(2.25,2.63)* 		1.08
(1.00,1.16)* 		1.00
(0.95,1.06) 		1.03
(0.95,1.10) 		1.29
(1.19,1.40)* 		38.69
(29.85,50.14)* 		1.00
(0.92,1.08)
Model II 1.34
(1.24,1.46)* 		1.03
(0.96,1.10) 		1.9
(1.7, 2.14)* 		2.51
(2.30,2.73)* 		1.07
(0.98,1.15) 		1.01
(0.95,1.08) 		1.03
(0.95,1.12) 		1.29
(1.18,1.41)* 		40.33
(30.45,53.43)* 		1.02
(0.94,1.11)
Model III 1.35
(1.24,1.47)* 		1.03
(0.96,1.10) 		1.9
(1.8, 2.19)* 		2.50
(2.30,2.72)* 		– – – 1.28
(1.17,1.40)* 		40.26
(30.36,53.40)* 		1.00
(0.92,1.09)
  1. * Statistically significant, BP blood pressure, TG triglycerides, FBG fasting blood glucose, HDL-C high-density lipoprotein-cholesterol, TC total cholesterol, LDL-C low-density lipoprotein cholesterol;
  2. overweight: BMI; 85th–95th; obesity, BMI > 95th; low HDL: < 40 mg/dL (except in boys 15–19 y old, that cut-off was < 45 mg/dL); high LDL: > 110 mg/dL; high TG: 100 mg/dL; high TC: > 200 mg/dL; elevated FBS > 100 mg/dL; high blood pressure: > 90th (adjusted by age, sex, height); Non–HDL-C concentration was calculated by subtracting HDL-C value from total cholesterol concentration. Diff-C was defined as the difference between total amount of non-HDL cholesterol and LDL-C (Diff-C = [non-HDL-C]-[LDL-C]). Atherogenic index as the ratio between TG and HDL-C concentrations
  3. Model 1: crude model
  4. Model 2: adjusted for age, sex, living area, screen time, SES and physical activity
  5. Model3: additionally adjusted for BMI except for overweight, obesity and abdominal obesity
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X